The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions.If you have any queries about the SPCs on our website then please e-mail

Tetanus Antitoxin Behring

Intervet Ireland LimitedVPA10996/150/001

Main Information

Trade NameTetanus Antitoxin Behring
Active SubstancesEquine serum protein
Dosage FormSolution for injection
Licence HolderIntervet Ireland Limited
Licence NumberVPA10996/150/001

Group Information

ATC CodeQI04AM02 clostridium antiserum
QI05AM01 clostridium antiserum
QI07AM Antisera, immunoglobulin preparations, and antitoxins
Therapeutic ClassImmunological- Antiserum


License statusAuthorised
Licence Issued09/04/2003
Legal StatusPOM: Prescription Only Medicine as defined in relevant national legislation


Summary of Product Characteristics *PDF Version
Package LeafletNo document available
Public Assessment ReportNo document available
VariationsNo document available

* The PDF document, together with the national-specific product information on this page, constitute the authorised SPC
« Back